CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 123 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $61,000 | -78.1% | 12,285 | -25.5% | 0.00% | -63.6% |
Q2 2018 | $278,000 | -90.8% | 16,500 | -87.5% | 0.01% | -89.2% |
Q1 2018 | $3,018,000 | -18.8% | 131,787 | -8.3% | 0.10% | -5.6% |
Q4 2017 | $3,718,000 | +324.4% | 143,703 | +142.0% | 0.11% | +272.4% |
Q3 2017 | $876,000 | – | 59,393 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |